Mason Street Advisors’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,776
| Closed | -$921K | – | 1457 |
|
|
2020
Q4 | $921K | Sell |
12,776
-49
| -0.4% | -$2.56K | 0.02% | 976 |
|
|
2020
Q3 | $585K | Buy |
12,825
+6
| +0% | +$251 | 0.01% | 1036 |
|
|
2020
Q2 | $579K | Buy |
12,819
+980
| +8% | +$43.9K | 0.01% | 1034 |
|
|
2020
Q1 | $456K | Hold |
11,839
| – | – | 0.01% | 1022 |
|
|
2019
Q4 | $548K | Buy |
11,839
+332
| +3% | +$14.4K | 0.01% | 1097 |
|
|
2019
Q3 | $469K | Buy |
11,507
+223
| +2% | +$9.63K | 0.01% | 1116 |
|
|
2019
Q2 | $543K | Buy |
11,284
+491
| +5% | +$25.8K | 0.01% | 1073 |
|
|
2019
Q1 | $676K | Buy |
10,793
+451
| +4% | +$31K | 0.01% | 1033 |
|
|
2018
Q4 | $618K | Buy |
10,342
+646
| +7% | +$38.8K | 0.02% | 973 |
|
|
2018
Q3 | $625K | Buy |
9,696
+699
| +8% | +$39K | 0.01% | 1028 |
|
|
2018
Q2 | $405K | Buy |
8,997
+424
| +5% | +$16.9K | 0.01% | 1153 |
|
|
2018
Q1 | $266K | Buy |
8,573
+577
| +7% | +$19K | 0.01% | 1255 |
|
|
2017
Q4 | $239K | Buy |
7,996
+210
| +3% | +$6.08K | 0.01% | 1281 |
|
|
2017
Q3 | $257K | Buy |
7,786
+720
| +10% | +$24.9K | 0.01% | 1244 |
|
|
2017
Q2 | $236K | Buy |
7,066
+432
| +7% | +$12.9K | 0.01% | 1246 |
|
|
2017
Q1 | $192K | Buy |
6,634
+465
| +8% | +$11.5K | ﹤0.01% | 1286 |
|
|
2016
Q4 | $138K | Buy |
6,169
+400
| +7% | +$7.82K | ﹤0.01% | 1356 |
|
|
2016
Q3 | $107K | Buy |
+5,769
| New | +$109K | ﹤0.01% | 1378 |
|
Other funds holding BEAT
Mason Street Advisors's BEAT Position: Q1 2021 in Review
Mason Street Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 12,776 shares — an estimated $921K sold.
Mason Street Advisors first reported a position in BEAT in Q3 2016 and held it in 18 quarters. The position peaked at $921K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Mason Street Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 12,776 BioTelemetry, Inc. shares in Q1 2021, an estimated $921K.
- Mason Street Advisors first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 18 quarters.
- Mason Street Advisors's BioTelemetry, Inc. position peaked at $921K in Q4 2020.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.